is a spin off company
from the Centre for Genomic Regulation (Barcelona - Spain)
founded by experienced entrepreneurs and funded
Pulmobiotics will use its technology to discover and develop novel treatments and vaccines for respiratory diseases, which are among the most common causes of severe illness and death worldwide.
Pulmobiotics | Platform | Respiratory diseases | Partners | Team | Contact
